Stock Comparison
IVVD vs UNH
Invivyd Inc vs UnitedHealth Group Inc
The Verdict
IVVD takes this one.
Head-to-Head
Market Cap
P/E Ratio
Profit Margin
Return on Equity
Debt-to-Equity
Overall Risk
DVR Score
The Deep Dive
Invivyd (IVVD) presents a compelling high-risk, high-reward opportunity, demonstrating significant improvement since our last analysis. The reported Q4 2025 earnings (March 5, 2026) were a major catalyst, showcasing a substantial revenue beat ($17.2M actual vs. $15.77M est.), a 31% sequential growth for PEMGARDA, and a remarkable 110% YoY revenue increase for FY 2025 to $53.4M. Critically, Q4 2025...
Full IVVD AnalysisUnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...
Full UNH AnalysisWant More Comparisons?
Run any stock through our deep value analyzer.
Analyze Any Stock →Not Financial Advice
This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.